Last updated 2026-06-18
- Raised funding round led by NFX Capital, Sep 2019
Total raised
—
Last: 2019-09
Stage
Seed
Founded
2019
Headcount
1
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
Gilboa Therapeutics is a preclinical-stage cancer immunotherapy company with a mission to dramatically improve outcomes and save lives. The company is focused on the development of SolidT, a next-generation cell therapy designed to harness the power of a patients own immune system to treat a wide range of cancers. SolidT cells are designed to deliver a highly specific and potent attack that has demonstrated complete eradication of tumors in animal models while leaving healthy tissue unharmed. Its innovative platform technology has the potential to benefit patients with a range of both solid and hematological tumors, with an improved safety profile compared to other cell therapy approaches.
Funding history · 1 round · — total
2019-09
Undisclosed
Q&A
- What is Gilboa Therapeutics' primary focus?
- Gilboa Therapeutics is a preclinical-stage cancer immunotherapy company focused on developing SolidT, a next-generation cell therapy designed to treat a wide range of cancers by harnessing a patient's immune system.
- When was Gilboa Therapeutics founded?
- Gilboa Therapeutics was founded in October 2019.
- What is the current status of Gilboa Therapeutics?
- Gilboa Therapeutics is currently inactive, having ceased operations in July 2025.
- How many employees does Gilboa Therapeutics have?
- Gilboa Therapeutics has 1-10 employees.
- Who is a co-founder of Gilboa Therapeutics?
- Yaron Carmi is a co-founder of Gilboa Therapeutics.
- What is Gilboa Therapeutics' current product stage?
- Gilboa Therapeutics' product is in the clinical trial stage.
- What is the primary sector of Gilboa Therapeutics?
- Gilboa Therapeutics operates in the Health Tech & Life Sciences sector.
- Which investor participated in Gilboa Therapeutics' funding round in September 2019?
- NFX Capital participated in Gilboa Therapeutics' funding round in September 2019.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2BB2C
Tags
cellstreatmentscancer
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/77733404 |
Identifiers & details
| Founded | 2019-10 |
|---|---|
| Employees (exact) | 1 |
| Status reason | Non Active, Jul 2025 ceased to operate |